Efficient Treatment of Sporothrix globosa Infection Using the Antibody Elicited by Recombinant Phage Nanofibers
Antifungal therapy is used to treat sporotrichosis. However, there are several limitations in this therapy, such as development of drug resistance and potential health risks including liver injury. The purpose of our study was to evaluate the antifungal efficacy of antibody against the hybrid phage...
Main Authors: | Feng Chen, Rihua Jiang, Shuai Dong, Bailing Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00160/full |
Similar Items
-
Th2 Biased Immunity With Altered B Cell Profiles in Circulation of Patients With Sporotrichosis Caused by Sporothrix globosa
by: Jianjiao Zu, et al.
Published: (2020-11-01) -
Genetic variation of Sporothrix globosa isolates from diverse geographic and clinical origins in China
by: Lipei Zhao, et al.
Published: (2017-01-01) -
Ploidy Determination in the Pathogenic Fungus Sporothrix spp.
by: Beatriz H. Ferreira, et al.
Published: (2019-02-01) -
Special Issue “Sporothrix and Sporotrichosis”
by: Héctor M. Mora-Montes
Published: (2018-10-01) -
Fixed cutaneous sporotrichosis in a patient with numerous fungal elements
by: Ankang Gu, et al.
Published: (2020-09-01)